OMX30 1 584 0,3%  OMXH25 3 776 0,2%  OMXC20 908 0,0%  Dow 20 659 -0,2%  Nas 5 430 0,4%  EUR 9,5494 0,0%  USD 8,8749 0,1%  Olja 52,5 0,1%  Guld 1 251 -0,1% 

Pfizer Aktie

305,00SEK 6,00SEK 2,01%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Pfizer

2016 2017e 2018e 2019e 2020e
Utdelning 1,20 1,28 1,46 1,44 1,52
Direktavkastning (i %) 3,69 3,76 4,31 4,23 4,49
PE-tal 13,54 13,27 12,21 11,82 11,13
Resultat/aktie 2,40 2,55 2,78 2,87 3,05

Nyheter om Pfizer Inc.

ytterligare nyheter

Analyser om Pfizer Inc.

Mar, 24 2017 Pfizer Outperform Bernstein Research
Mar, 23 2017 Pfizer Hold Société Générale Group S.A. (SG)
Mar, 16 2017 Pfizer Overweight Barclays Capital
Mar, 13 2017 Pfizer Outperform Credit Suisse Group
Mar, 13 2017 Pfizer Outperform Bernstein Research
ytterligare analyser

Pfizer Peer Group

Abbott Laboratories 44,68
0,0%
Alexion Pharmaceuticals 120,73
1,9%
AstraZeneca 554,50
0,5%
Bayer 106,90
0,0%
Celgene 124,08
-0,3%
EVOTEC 8,94
1,6%
Gilead Sciences 67,27
0,3%
GlaxoSmithKline 16,79
0,1%
Johnson & Johnson 124,97
-0,5%
Merck 63,63
0,5%
Merck 104,25
0,4%
MorphoSys 54,20
-0,5%
Mylan 40,36
-3,2%
Novartis 74,50
1,0%
Pfizer 34,34
0,5%
Roche 254,75
0,7%
STADA Arzneimittel 57,23
0,2%
Sanofi 84,51
0,7%
Teva Pharmaceutical Industries 33,05
0,3%
Vertex Pharmaceuticals 107,99
20,4%
pagehit

Lägg till instrument

Vad tycker du?

Profil Pfizer Inc.

till bolagsprofilen
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Realtidskurs Pfizer Inc.

Bid
31,87
EUR
Ask
31,93
EUR
Kurstid
08:29
Börsen STU

Aktiekurs Pfizer Inc. i SEKPUSH CHART

Kurs 305,00 SEK 6,00 2,01 %
Kurstid 17:29:47
Datum 29.03.2017
Öppning 0,00
Gårdagen 305,00
Dagshögsta 0,00
Dagslägsta 0,00
52 v. högsta 320,00
52 v. lägsta 235,00
52 v. perf.
Volym (Antal) 0
Börsvärde (SEK) 1 815,43 Mrd
Börsen

Till aktien Pfizer

Ticker PFE
ISIN US7170811035
Index Dow Jones, S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

Struktuerarde produkter på Pfizer

Produkttyp Antal
Mini Futures 3

Pfizer Nyckeltal

Börsvärde i SEK 1 815,43 Mrd
Free float % 99,94
Antal aktier mio. 5 955,13
Cashflow/aktie i lokal valuta 2,13
Bokvärde/aktie i lokal valuta 9,67
60 dagar vola 16,06
PBV 3,36

Pfizer Historiska kurser

2017-03-29 305,00 2 415
2017-03-28 299,00 936
2017-03-27 300,00 3 117
2017-03-24 300,00 1 331
2017-03-23 304,00 2 248

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 813,5 %
Exelixis Inc. 466,2 %
EXACT Sciences Corp. 281,8 %
Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %